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Despite the complexity of the oncogenesis in general and the photocarcinogenesis in 
particular, it is consensually accepted that actinic radiation is one of the main causes of 
skin cancer. The scientific arguments that support this concept are the increase of the 
incidence and prevalence of squamous cell and basal cell carcinomas in exposed skin 
areas, the increased incidence of these tumours in lower latitudes, and, in what the 
individual is concerned, his cutaneous pigmentation, outdoor activity and geographical 
area of origin. Experimental data also increasingly point to the responsibility of the 
ultraviolet B (U.V.B.) radiation in the etiopathogeny of these tumours, although, in what 
concerns malignant melanoma, the situation is to a great extent more complex.  
 
Among the several types of actinic radiation that reach the earth surface, ultraviolet A 
and B (U.V.A. and U.V.B) radiation is considered the most significant in inducing 
malignant skin tumours. Nevertheless, there is increasing evidence of the potential 
oncogenicity of visible and infrared radiations. Ultraviolet C (U.V.C.) rays are totally 
retained in the ozone layer; as for the U.V.B., despite an important percentage being 
retained there, a relevant quantity still reaches the epidermal superficial layers, although 
only 1% is able to reach the deep dermis; on the other hand, the U.V.A., that were 
thought not to have a relevant role in tumoral genesis, appear today with a greater 
importance in inducing the most serious cutaneous malignancies, namely melanoma. 
This seems to result from their capacity to intensively reach the dermo-epidermal 
junction, deeply penetrate in the dermis and furthermore play a relevant role in inducing 
local and systemic immune suppression.  
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The three most important means of solar energy protection are natural protection, the 
protection achieved by the intake of systemic drugs and the protection resulting from 
the use of topic agents, broadly named sunscreens. 
 
 
Natural Protection 
 
Natural protection of each individual is assured by the queratinization process that 
regulates the thickness and the cohesion of the stratum corneum; the melanic 
pigmentation which occurs exclusively from eumelanin or black melanin (that 
disperses, absorbs and transforms photonic energy in heat or vibration and is also an 
active captor of free radicals); the cutaneous and subcutaneous accumulation of 
carotenes; the urocanic acid (a substance released in the sweat, synthesised from 
histidine and with the capacity to absorb actinic radiation); the anti-oxidant cutaneous 
system (superoxide dismutase, catalase, peroxidase and glutathione reductase) and by 
the sophisticated mechanisms of DNA repair and replication. 
 
It is this genetically determined ability of defence from actinic radiation that allows us 
to classify the human being in six skin phototypes: ranging from phototype VI, of dark-
skinned people, almost invulnerable to actinic radiation, who never get sunburned and 
are deeply pigmented, to phototype I, of extraordinary sensitive skins, who always get 
sunburned and rarely tan (for instance, associated with red-haired individuals). Between 
subtypes I and VI there are gradative variations that result, among other factors, from 
the quantitative existing relation between eumelanin – black melanin – with a defence 
ability, and pheomelanin – yellow melanin – that contains cistein and has the capacity to 
induce the creation of free radicals, therefore having a significant aggressive potential. 
The Mediterranean Caucasians, to which the majority of us belong to, are complex 
mosaics of both these melanins and are classified in phototypes III or IV. 
 
Several authors consider the albinism as phototype 0. These patients are extremely 
sensitive to the sun, resulting from their genetic incapacity to synthesise melanin due to 
varied deficiencies of the enzyme tyrosine hydroxilase. 
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The clinic paradigm encompassing all these concepts and the genetic ability of defence 
from actinic radiation is xeroderma pigmentosum – an autossomic recessive disease 
based on a genetic defect in the enzyme mechanisms of DNA detection and/or repair, 
which leads to the development of successive, both benign and malignant, tumoral 
cutaneous lesions. One of these tumors, generally before the age of twenty, becomes 
more aggressive, creating metastases that lead to death. 
 
 
The inefficiency of systemic protection 
 
Several orally-taken drugs have been experimented, such as p-aminobenzoic acid 
(PABA) and p-aminosalicilic acid (PASA) (in an analogy with topic treatments), as well 
as triprolidine, unsaturated fatty acids and several vitamins (A, C, E). Only carotene, 
taken for four to six weeks, can induce a level of protection that does not exceed 2,5, 
being, nevertheless, from the preventive and therapeutic point of view, scarcely 
efficient.  
 
 
Filters versus physical blockers 
 
There are essentially two types of substances in topic agents: ultraviolet filters – p-
aminobenzoic acid (PABA) and derivatives, benzophenones, benzimidazoles, camphor 
derivatives, cinnamates, salicylates, methylanthranilates, dibenzoylmethanates – 
photoactive chemical substances, capable of receiving and dispersing the radiation (in 
theory, since, like eumelanin, they transform photonic energy in vibration or heat). They 
are cosmetically pleasant and very effective against U.V.B. Against U.V.A. only 
benzophenones and dibenzoylmethanates present some ability of defence. However, 
against U.V.A. of long wavelength, i.e., above 370-380nm, none of them is effective. 
On the other hand, the physical blocking agents (titanium dioxide, zinc oxide, talc, 
magnesium salicylate, kaolin and others), that constitute a physical barrier to the 
penetration of U.V. radiation, do not have a privileged efficiency in any wavelength, 
and are cosmetically unpleasant. As long as they are formulated in adequate sizes of 
particles they are capable to inhibit, in an effective way, the penetration of all actinic 
radiation. Nonetheless, with the aim of making physical blockers more acceptable from 
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a cosmetic point of view, the pharmaceutical industry has been reducing the size of 
particles in general, and namely those of titanium dioxide and zinc oxide (for diameters 
below 30nm), providing the final preparation a spectre of absorbance quite similar to 
dibenzoylmethanates, with great efficiency for U.V.B., but without an effective 
protection capacity above 370-380 nm, that is for U.V.A. of long wavelength. 
 
 
A few questions 
 
The most pertinent questions from a technical, scientific and clinical practice-related 
point of view when dealing with sun protection are: 1) the methodology of protection 
factors determination; 2) the objective conditionings of the suggested protection factor; 
3) the doubt over the existence of an effective U.V.A. protection and, in case of non-
existence, its possible consequences; 4) the existence or non-existence of a co-relation 
between physiopathological paths of inducing the erythema and the changes conducting 
to delayed deleterious actions of U.V. 
 
In what concerns U.V.B., it is, since long, consensual that the capacity to inhibit the 
erythema determines the protection factor of a certain formulation. In this sense, the 
protection factor or coefficient is the relation between the minimal dosage of erythema 
with photoprotector and the minimal dosage of erythema without photoprotector. 
 
The consensus is taking longer to emerge when it comes to determining the U.V.A. 
protection factor. To achieve such goal, one can simply use erythema, the erythema 
induced by U.V.A. post-systemic administration of a photosensibilising drug – a 
psoralen, the immediate pigmentation induced by U.V.A. (I.P. – U.V.A.) and also 
delayed pigmentation (L.P. – U.V.A.). 
 
In what protection factor conditionings are concerned, in other words, the real 
consonance between the suggested factor and the objective achieved protection, it is 
essential that the formulation of the sunscreen has substantivity (capacity to penetrate 
and fixate to the corneum stractum), remanence (capacity to resist water and sudation) 
and is photostable (is not degraded during solar radiation exposure, which substantially 
reduces its photoprotection capacity). On the other hand, it would be necessary to apply 
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34g of sunscreen each time – which is practically a whole tube – if one has into 
consideration the 1,7m2 of corporal surface of an adult, to be able to reach the 
concentration of 2mg/cm2, with which most tests for determining the protection factor 
are conducted. When applied “only” 1mg/cm2 (17g of sunscreen for the corporal surface 
of an adult), the suggested protection factor decreases exponentially (for example, a 
protection factor 15 decreases to 3.9). In this sense, there is an almost total incapacity to 
achieve, in practice, the protection factor that is indicated. 
 
There is indeed no efficient sun protection against U.V.A. of wavelengths between 370-
380 nm, whether with physical agents composed by microparticles or with chemical 
agents currently available. The scientific arguments that allow us to conclude that there 
is no evident relation between inducing solar erythema and delayed deleterious actions 
from ultraviolets are quite substantial. For instance, indometacine is capable of 
inhibiting solar erythema, although not having any action in cellular changes induced by 
ultraviolet rays, while cimetidine, acting at an immune level, inhibits the 
photocarcinogenesis induced by U.V.B. in the rat, although not having any action at the 
erythema inducing level. Even sunscreens with great efficiency in preventing solar 
erythema have a null or reduced action in relation to the inhibition of local or systemic 
immune suppression induced by U.V.B. 
 
Another notion that we consider of practical interest is that the classification of 
protection factors with levels superior to 15 is, according to us, incorrect and can only 
have commercial aims. A protection factor of 15 implies that our natural protection is 
amplified 15 times (i. e., only 1/15 (6,6%) of solar radiation is capable of penetrating 
the epidermis, 93,4% of it being absorbed or reflected). A protection factor of 30, that 
may appear to double the capacity of a protection factor of 15, means objectively that 
only 1/30 (3,3%) of the radiation can enter the cutaneous surface, 96,7% being retained. 
Thus, the difference between a factor 15 and a factor 30 is irrelevant from the point of 
view of its photoprotection capacity. 
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The controversies 
 
Firstly, we shall go into the “epidemiologic polemic”. This is based in the fact that in a 
few Australian provinces sunscreens are used from the age of three, due to prevention 
campaigns apparently very well conducted, despite the increase of the incidence of the 
malignant melanoma – being Queensland, in the Northeast of Australia, the highest in 
the world. European studies corroborate this concern and show the increase of the 
incidence of basal cell carcinoma in women (1) and of melanoma in men (2, 3) that use 
sunscreens. 
 
A second question can be presented as the “U.V.A. polemic”. Considering the relevant 
efficiency we have against U.V.B., associated with the difficulty against U.V.A. 
protection, the sunburn, which would function as a physiologic alarm bell to end or 
suspend sun exposure, does not occur, thus allowing an excessive exposure. Therefore 
sun exposures can be maintained, with apparent safety, for five hours – which, for 
instance in the summer and at our latitude, correspond to enormous dosages of U.V.A. 
(approximately of 100 J/cm2), which nobody knows the whole effect but that are, in the 
light of current knowledge, extremely damaging at the organic cellular and functional 
level. 
 
Another debate is the fact that besides inducing changes at the DNA of all epidermal 
cells, ultraviolet radiation also induces local and systemic immune suppression, which, 
among other facts of physiopathological relevance, damages the whole oncologic 
system of surveillance. Further aggravating the situation, this photo-immune 
suppression is independent of the phototype and is not substantially altered by the use of 
sunscreens – chemical protectors. In what concerns physical blockers, there are no 
definite data, although less damaging results are expected as long as the size of the 
physical particles is adequate. 
 
It should be underlined as well that during an effective sun protection against U.V.B. 
there is a reduction of serum concentrations of vitamin D and is therefore essential to 
offer supplements of this vitamin, particularly to the elderly. 
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Supported by evidence-based medicine, we must emphasise these polemic issues that 
seem to us relevant for a deep technical and scientific reflection and that basically 
question the fact that sunscreens should maintain their status as cosmetics or, if due to 
the questions they raise and the public health problems that might be implicated, should 
have the legal status of a drug. 
 
On the other hand and for exactly the same reason, it should also be discussed 
legislation that prohibits the irradiation by U.V.A. in “tanning beds” or other cosmetic 
treatments without specialised medical control. 
 
 
The future 
In what concerns the future, the search for protections against U.V.A. as actives as the 
ones against U.V.B. should be a priority for scientific research. Ironically hats and 
swimming suits, these days so out-of-fashion, may well be part of the future of sun 
protection, as well as filters and physical blockers of medium and big particles, despite 
being cosmetically unpleasant.  
 
We should make clear that in fighting against the increasing incidence of skin cancer, 
particularly melanoma that rises all over the world 7 to 10% per year, the most 
important is the timely recognition of suspicious lesions, the capacity to proceed to a 
diagnostic biopsy or promptly refer the patient to a specialised unit. Only in this manner 
will it be possible to fight this real epidemic that is currently malignant melanoma and 
for which the only adequate weapon is precocious diagnosis. 
 
To help out, there is a mnemonic that synthesises the clinical characteristics of a 
cutaneous lesion suspicious of malignant melanoma, and that we designate as A, B, C, 
D, E of Melanoma: A – Asymmetry; B – Border Irregularity; C – Colour irregularity; D 
– Diameter over 8mm; E – Elevation. 
 
In our opinion and at the stadium of current knowledge, the scientific truth is that a 
sunscreen is merely a modest support in the fight against skin cancer and that, in face of 
an overwhelming publicity, it is vital to dismount the false safety that its use can 
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transmit. In other words, it should be emphasised that the use of sunscreen is only useful 
if the exposure with its protection is as prolonged as it would be without it. 
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